Skip to content
healthcare.dev
Get a free key

Alfuzosin hydrochloride

NDC 76282-302, Alfuzosin hydrochloride, tablet, extended release, from Exelan Pharmaceuticals Inc..

Product NDC
76282-302
Status
Listed
Labeler
Exelan Pharmaceuticals Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090284
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-302 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALFUZOSIN HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
76282-302-0176282030201100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-01)
76282-302-0576282030205500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-05)
76282-302-10762820302101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-10)
76282-302-1276282030212120 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-12)
76282-302-907628203029090 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f075a897-7bef-4799-b7e2-7e051c461443

  • NADAC price for package 76282030201

    GET /v1/drugs/nadac/76282030201

  • NADAC price for package 76282030205

    GET /v1/drugs/nadac/76282030205

  • NADAC price for package 76282030210

    GET /v1/drugs/nadac/76282030210

  • NADAC price for package 76282030212

    GET /v1/drugs/nadac/76282030212

  • NADAC price for package 76282030290

    GET /v1/drugs/nadac/76282030290

Use it

Look up 76282-302 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-302 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-302. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.